853PPREDICTION OF RESPONSE OF PRIMARY TUMORS TO NEOADJUVANT SUNITINIB USING PERFUSION (DCE) COMPUTED TOMOGRAPHY (CT) IN METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS (PREINSUT TRIAL).